Tear proteomics reveals the molecular basis of the efficacy of human recombinant nerve growth factor treatment for Neurotrophic Keratopathy
Open Access
- 24 January 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-11
Abstract
Neurotrophic Keratopathy (NK), classified as an orphan disease (ORPHA137596), is a rare degenerative corneal disease characterized by epithelial instability and decreased corneal sensitivity caused by the damage to the corneal nerves. The administration of human recombinant nerve growth factor (rhNGF) eye drops, as a licensed-in-Europe specific medication for treatment of moderate and severe NK, has added promising perspectives to the management of this disorder by providing a valid alternative to the neurotization surgery. However, few studies have been conducted to the molecular mechanism underlying the response to the treatment. Here, we carried out tears proteomics to highlight the protein expression during pharmacological treatment of NK (Data are available via ProteomeXchange with identifier PXD025408).Our data emphasized a proteome modulation during rhNGF treatment related to an increase in DNA synthesis, an activation of both BDNF signal and IL6 receptor. Furthermore, the amount of neuronal Extracellular Vesicles EVs (CD171+) correlated with the EVs carrying IL6R (CD126+) together associated to the inflammatory EVs (CD45+) in tears. Such scenario determined drug response, confirmed by an in vivo confocal microscopy analysis, showing an increase in length, density and number of nerve fiber branches during treatment. In summary, rhNGF treatment seems to determine an inflammatory micro-environment, mediated by functionalized EVs, defining the drug response by stimulating protein synthesis and fiber regeneration.Keywords
This publication has 40 references indexed in Scilit:
- Diagnosis and management of neurotrophic keratitisClinical Ophthalmology, 2014
- Causal analysis approaches in Ingenuity Pathway AnalysisBioinformatics, 2013
- The role of corneal afferent neurons in regulating tears under normal and dry eye conditionsExperimental Eye Research, 2013
- BDNF: The career of a multifaceted neurotrophin in spinal cord injuryExperimental Neurology, 2012
- The role of nerve growth factor in hyperosmolar stress induced apoptosisJournal of Cellular Physiology, 2008
- Human leukocyte elastase and cathepsin G are specific inhibitors of C5a‐dependent neutrophil enzyme release and chemotaxisExperimental Dermatology, 2004
- DJ‐1 has a role in antioxidative stress to prevent cell deathEMBO Reports, 2004
- Neurotrophic keratitisEye, 2003
- Effect of Brain-Derived Neurotrophic Factor, Nerve Growth Factor, and Neurotrophin-3 on Functional Recovery and Regeneration After Spinal Cord Injury in Adult RatsJournal of Neurotrauma, 2000
- Degradation of Outer Membrane Protein A in Escherichia coli Killing by Neutrophil ElastaseScience, 2000